Zenas BioPharma, Inc. (ZBIO)

It’s going to be a volatile year. Read some of the smarter money folks on why.

Meanwhile, ZBIO took a nose dive yesterday, and is still shedding market cap this morning, because of what seem to be just rumors that they may have a hard time coming to market. If approvals are delayed too long, they may need to do some dilution to get to market, but they have a strong pipeline and decent war chest.

My alerts are set to $13 and $19 for re-evaluation.

Invest in your karma by sharing this if you found it valuable

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.